Please use this identifier to cite or link to this item:
https://repository.monashhealth.org/monashhealthjspui/handle/1/52580
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | MacPhail A. | - |
dc.contributor.author | Chraiti M.-N. | - |
dc.contributor.author | Zanella M.-C. | - |
dc.contributor.author | Hassoun-Kheir N. | - |
dc.contributor.author | Catho G. | - |
dc.contributor.author | Nguyen A. | - |
dc.contributor.author | Harbarth S. | - |
dc.contributor.author | Buetti N. | - |
dc.date.accessioned | 2024-10-16T01:56:23Z | - |
dc.date.available | 2024-10-16T01:56:23Z | - |
dc.date.copyright | 2024 | - |
dc.date.issued | 2024-10-04 | en |
dc.identifier.citation | International Journal of Infectious Diseases. (pp 107247), 2024. Date of Publication: 27 Sep 2024. | - |
dc.identifier.uri | https://repository.monashhealth.org/monashhealthjspui/handle/1/52580 | - |
dc.description.abstract | OBJECTIVES: Catheter-associated bloodstream infections (CABSI) cause preventable morbidity. We compared the microbiological aetiology of CABSI across different types of central and peripherally inserted catheters. METHOD(S): We analysed prospectively collected CABSI data in a 2100-bed hospital network in Switzerland between 2016 and 2022. We included: short-term non-tunnelled central venous catheters (CVC); long-term catheters (tunnelled, or peripherally inserted central catheters); arterial catheters; dialysis catheters; and peripheral venous catheters (PVC). We used multivariable logistic regression models to describe risk of Staphylococcus aureus and Gram-negative pathogens according to catheter type. RESULT(S): 416 CABSI episodes were included, including 60 episodes of S. aureus and 92 episodes of Gram-negative CABSI. Microbiological profile differed between catheter types. Together, PVC and dialysis catheters accounted for 43/60 (72%) of all S. aureus CABSI. After adjusting for age, sex and haematology/oncology care, odds of S. aureus were higher for haemodialysis catheters (OR 17.3, 95% CI 5.75-52.2, p <0.01) and PVC (OR 2.96, 95% CI 1.22-7.20, p=0.02) compared to short-term non-tunnelled CVC. Odds of Gram-negative organism as cause of CABSI were higher in long-term catheters versus short-term non-tunnelled CVC (OR 2.70, 95% CI 1.37-5.24). CONCLUSION(S): CABSI in catheters other than short-term non-tunnelled CVC are more commonly caused by virulent organisms including S. aureus and Gram-negative bacteria. Catheter type should be considered when selecting empirical antimicrobial therapies.Copyright © 2024. Published by Elsevier Ltd. | - |
dc.relation.ispartof | International Journal of Infectious Diseases | - |
dc.subject.mesh | antimicrobial activity | - |
dc.subject.mesh | catheter related bloodstream infection | - |
dc.subject.mesh | hospital infection | - |
dc.title | Microbiology of catheter associated bloodstream infection: differences according to catheter type. | - |
dc.type | Article | - |
dc.identifier.affiliation | Infectious Diseases and Clinical Microbiology | - |
dc.type.studyortrial | Observational study (cohort, case-control, cross sectional, or survey) | - |
dc.identifier.doi | http://monash.idm.oclc.org/login?url=https://dx.doi.org/10.1016/j.ijid.2024.107247 | - |
dc.publisher.place | Canada | - |
dc.identifier.pubmedid | 39343125 [https://www.ncbi.nlm.nih.gov/pubmed/?term=39343125] | - |
dc.identifier.institution | (MacPhail) Infection Control Program and WHO Collaborating Centre, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland; Department of Infectious Diseases, Monash Health, Melbourne, Australia; School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia | - |
dc.identifier.institution | (Chraiti, Zanella, Hassoun-Kheir, Catho, Nguyen, Harbarth) Infection Control Program and WHO Collaborating Centre, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland | - |
dc.identifier.institution | (Buetti) Infection Control Program and WHO Collaborating Centre, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland; Infection Antimicrobials Modeling Evolution (IAME) U 1137, INSERM, Universite Paris-Cite, Paris, France | - |
dc.identifier.affiliationmh | (MacPhail) Infection Control Program and WHO Collaborating Centre, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland; Department of Infectious Diseases, Monash Health, Melbourne, Australia; School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia | - |
item.openairetype | Article | - |
item.cerifentitytype | Publications | - |
item.grantfulltext | none | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.fulltext | No Fulltext | - |
Appears in Collections: | Articles |
Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.